TRHC - Tabula Rasa HealthCare, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
48.51
-0.63 (-1.28%)
As of 9:39AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close49.14
Open49.28
Bid0.00 x 1000
Ask75.00 x 900
Day's Range48.50 - 49.28
52 Week Range40.86 - 91.16
Volume4,146
Avg. Volume354,282
Market Cap992.35M
Beta (3Y Monthly)1.66
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Insiders Increased Their Holdings
    Simply Wall St.13 days ago

    Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Insiders Increased Their Holdings

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...

  • NXGN vs. TRHC: Which Stock Is the Better Value Option?
    Zacks19 days ago

    NXGN vs. TRHC: Which Stock Is the Better Value Option?

    NXGN vs. TRHC: Which Stock Is the Better Value Option?

  • NXGN or TRHC: Which Is the Better Value Stock Right Now?
    Zackslast month

    NXGN or TRHC: Which Is the Better Value Stock Right Now?

    NXGN vs. TRHC: Which Stock Is the Better Value Option?

  • Tabula Rasa HealthCare, Inc. Common Stock (TRHC) Q1 2019 Earnings Call Transcript
    Motley Foollast month

    Tabula Rasa HealthCare, Inc. Common Stock (TRHC) Q1 2019 Earnings Call Transcript

    TRHC earnings call for the period ending March 31, 2019.

  • Tabula Rasa Healthcare (TRHC) Q1 Earnings and Revenues Surpass Estimates
    Zackslast month

    Tabula Rasa Healthcare (TRHC) Q1 Earnings and Revenues Surpass Estimates

    Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 66.67% and 2.90%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Presslast month

    Tabula Rasa Healthcare: 1Q Earnings Snapshot

    On a per-share basis, the Moorestown, New Jersey-based company said it had a loss of 54 cents. Earnings, adjusted for stock option expense and amortization costs, came to 10 cents per share. The results ...

  • 2 Healthcare Innovators To Buy Now
    Zackslast month

    2 Healthcare Innovators To Buy Now

    My innovation radar is hot on the trail of genetic diagnostics and advanced medical records IT.

  • Tabula Rasa, Tesla, Roku and Netflix as Zacks Bull and Bear of the Day
    Zacks2 months ago

    Tabula Rasa, Tesla, Roku and Netflix as Zacks Bull and Bear of the Day

    Tabula Rasa, Tesla, Roku and Netflix as Zacks Bull and Bear of the Day

  • Bull of the Day: Tabula Rasa HealthCare (TRHC)
    Zacks2 months ago

    Bull of the Day: Tabula Rasa HealthCare (TRHC)

    Bull of the Day: Tabula Rasa HealthCare (TRHC)

  • Here’s What Hedge Funds Think About Tabula Rasa HealthCare, Inc. (TRHC)
    Insider Monkey2 months ago

    Here’s What Hedge Funds Think About Tabula Rasa HealthCare, Inc. (TRHC)

    We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of December 31st. In this article, we look at what those funds think of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) based on […]

  • Earnings Preview: Tabula Rasa Healthcare (TRHC) Q1 Earnings Expected to Decline
    Zacks2 months ago

    Earnings Preview: Tabula Rasa Healthcare (TRHC) Q1 Earnings Expected to Decline

    Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • CERN vs. TRHC: Which Stock Is the Better Value Option?
    Zacks2 months ago

    CERN vs. TRHC: Which Stock Is the Better Value Option?

    CERN vs. TRHC: Which Stock Is the Better Value Option?

  • Did You Miss Tabula Rasa HealthCare's (NASDAQ:TRHC) 29% Share Price Gain?
    Simply Wall St.2 months ago

    Did You Miss Tabula Rasa HealthCare's (NASDAQ:TRHC) 29% Share Price Gain?

    It hasn't been the best quarter for Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) shareholders, since the share price has fallen 16% in that time. But that doesn't change the reality that over twelve months the stock has don...

  • Zacks2 months ago

    S&P Approaches New Highs After Crossing Above 2900

    S&P; Approaches New Highs After Crossing Above 2900

  • CERN or TRHC: Which Is the Better Value Stock Right Now?
    Zacks2 months ago

    CERN or TRHC: Which Is the Better Value Stock Right Now?

    CERN vs. TRHC: Which Stock Is the Better Value Option?

  • 3 Beaten-Down Stocks Ready to Pop
    TipRanks3 months ago

    3 Beaten-Down Stocks Ready to Pop

    Some of the biggest gains can come from buying stocks that are undervalued by the market. The stocks covered below have struggled recently. But when you take a closer look, the setup for these stocks is actually very compelling right now. That's according to the Street's top performing analysts. They are predicting significant gains in the coming months. How can you find such stocks? Here we used TipRanks' Top Analysts Stocks tool. The tool allows you to select stocks with a 'Strong Buy' Street consensus, that have underperformed over the last three months. We also scanned for stocks that have serious upside potential from the current share price to the average analyst price target. Let's take a closer look at the 3 stocks that made the cut now: Health Insurance Innovations (HIIQ)Health insurance stock HIIQ (HIIQ– Research Report) is poised to rebound. On a one-month basis shares have crashed by 28%, but the result is that the stock now looks extremely inexpensive.Prompting the selffoff was the news that the House Energy and Commerce Committee launched an investigation into roughly a dozen STM (short-term medical) market participants including HIIQ. The investigation is requesting information on STM marketing practices, enrollment channels and data, commissions and complaints and various other matters.However analysts are staying firmly on side. Northland’s Michael Grondahl (Track Record & Ratings) calls the selloff ‘excessive’. He stamps a ‘top pick’ status on Health Insurance with an $85 price target, suggesting upside potential of over 200%! “HIIQ added another $100M to its stock buyback authorization and clearly sees the value we believe exists in the shares” writes the Top 100 analyst.Grondahl isn’t too concerned about the investigation. “We highlight HIIQ operations have recently been thoroughly scrutinized by the two plus years 42 state investigation which had no findings and no issues” he writes. “We believe if there was a serious issue it would have been found in the last two years.” Further any near-term legislation relating to limited duration plans has ‘no chance of passing the Senate.’ Indeed, no less than seven analysts have come out in support of HIIQ over the last three months:View HIIQ Price Target & Analyst Ratings Detail Conn’s (CONN)Home furnishings specialist Conn's Inc (CONN– Research Report) sells everything from computers to reclining sofas. It also offers a whole range of financing options with store credit cards and lease-to-own programs. The past several years proved tumultuous for CONN, as the company struggled to balance its credit and retail operations. However, under the direction of new CEO Norm Miller, and a fresh team of senior leaders, the CONN credit business is on a much more solid footing, supporting a return to expansion in retail. “We have been recommending CONN as a compelling, under-the-radar retail turnaround play for some time now. We remain decidedly impressed with the efforts of CEO Norm Miller and his team to not only fix, but substantially repair the company’s once ailing credit business” writes Oppenheimer’s Brian Nagel (Track Record & Ratings). While retail sales have been disappointing lately, Nagel views it as only a matter of time before CONN finds the right formula to better connect with consumers. He concludes: “The market appears to meaningfully underappreciate the nearer- and longer-term EPS power of a better-functioning CONN business model.”With a $40 price target, Nagel sees 75% upside potential for CONN. He is one of three analysts who have published recent ratings on the stock, all of which are a ‘Buy’:View CONN Price Target & Analyst Ratings Detail Tabula Rasa Healthcare (TRHC)Tabula Rasa (TRHC– Research Report) is a groundbreaking tech healthcare company. It’s cloud-based software empowers healthcare providers to create personalized programs for patients. The result: optimized medication regimens, improved patient outcomes and reduced medication risk. Meanwhile health care providers enjoy operational efficiencies and reduced medical costs. Five-star Cantor Fitzgerald analyst Steven Halper (Track Record & Ratings) has a Street-high $99 price target on TRHC. That suggests shares can explode 75% from current levels.“We believe the company should be able to successfully leverage its unique medication risk management technology in many different markets” he explains. “The company's revenue mix is improving with growth in its Enhanced Medication Therapy Management (EMTM) program and are likely to drive margins higher over time” the analyst continues. He has his eye on a recent White House report that alludes to support for TRHC solutions. The report discusses innovations with the potential to improve the lives of the elderly and the disabled. In particular, it mentions solutions that would allow clinicians to maintain proper dosing and reduce the simultaneous use of multiple medications.“We believe TRHC's MedWise software and RxCompanion platform would be suitable for these applications. Additionally, we believe government support for such medication risk mitigation tools represent a nice tailwind for TRHC” writes Halper. Overall, six out of seven analysts covering the stock rate TRHC a ‘Buy’, giving it a ‘Strong Buy’ consensus. Their average price target stands at $87.20…View TRHC Price Target & Analyst Ratings Detail Also check out: Spirit Airlines (SAVE)Ultra-low-cost carrier Spirit Airlines, Inc. (SAVE– Research Report) is the seventh largest commercial airline in the US. And the stock looks like a tremendous bargain right now. Shares are currently trading down 9% year-to-date. The company has been plagued by higher fuel prices, while conservative FY20 unit revenues also spooked investors. Indeed, top-rated Imperial Capital analyst Michael Derchin (Track Record & Ratings) has just slashed his price target from $92 to $83.However that’s only part of the story. First, even the $83 price target indicates substantial upside potential of 57%. Second, Derchin calls Spirit Airlines his top pick in the airline industry. He believes the stock represents an appealing opportunity, currently trading at just 7.0x FY20E EPS. Strong pricing power, strong ancillary revenue growth and key initiatives like revamping the website and frequent flier program should help drive growth says Derchin. That’s on top of ‘significantly improved’ operational efficiency resulting in top-tier margins and a potential credit card agreement with Bank of America.Encouragingly, the Street shares this upbeat outlook. Out of the 9 analysts polled by TipRanks over the last three months, all 9 rate the stock a buy. With a $77 average analyst price target, these analysts are forecasting 46% upside potential. View SAVE Price Target & Analyst Ratings Detail Enjoy the Research Report on the Stocks in this Article:Conn's Inc (CONN) Research ReportHealth Insurance Innovations Inc (HIIQ) Research ReportSpirit Airlines Inc (SAVE) Research ReportTabula Rasa HealthCare Inc (TRHC) Research ReportFind fresh investing inspiration with the TipRanks Analysts’ Top Stocks tool. Using this recently revamped tool you can find the latest stock picks from analysts that consistently outperform. Discover ‘Strong Buy’ stocks in the sector that interests you. Go to Analysts’ Top Stocks now.

  • Tabula Rasa CEO said his company is done making acquisitions, for now
    American City Business Journals3 months ago

    Tabula Rasa CEO said his company is done making acquisitions, for now

    South Jersey medical technology company Tabula Rasa culminated an active shopping spree last week with its fifth acquisition in less than two years. The company, which helps health care providers manage medication risk and prevent adverse drug reactions, paid $150 million for PrescribeWellness. California-based PrescribeWellness is the developer of software used by community pharmacies to predict and better manage work flow.

  • Should You Think About Buying Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Now?
    Simply Wall St.3 months ago

    Should You Think About Buying Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Now?

    Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), which is in the healthcare services business, and is based in United States, saw a double-digit share price rise of over 10% in the pastRead More...

  • Tabula Rasa acquires pharmacy software firm for $150M
    American City Business Journals3 months ago

    Tabula Rasa acquires pharmacy software firm for $150M

    The deal will bring Tabula Rasa's medication risk mitigation technology to more community pharmacies.

  • Tabula Rasa HealthCare, Inc. (TRHC) Q4 2018 Earnings Conference Call Transcript
    Motley Fool4 months ago

    Tabula Rasa HealthCare, Inc. (TRHC) Q4 2018 Earnings Conference Call Transcript

    TRHC earnings call for the period ending December 31, 2018.

  • Tabula Rasa Healthcare (TRHC) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks4 months ago

    Tabula Rasa Healthcare (TRHC) Reports Next Week: Wall Street Expects Earnings Growth

    Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • What Kind Of Share Price Volatility Should You Expect For Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?
    Simply Wall St.4 months ago

    What Kind Of Share Price Volatility Should You Expect For Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you own shares in Tabula Rasa Read More...

  • Tabula Rasa completes $20M acquisition of Australian medical software company
    American City Business Journals5 months ago

    Tabula Rasa completes $20M acquisition of Australian medical software company

    The seller is an Australian company that has developed software to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs.

  • CPSI vs. TRHC: Which Stock Should Value Investors Buy Now?
    Zacks6 months ago

    CPSI vs. TRHC: Which Stock Should Value Investors Buy Now?

    CPSI vs. TRHC: Which Stock Is the Better Value Option?

  • Should You Be Worried About Insider Transactions At Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?
    Simply Wall St.6 months ago

    Should You Be Worried About Insider Transactions At Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?

    It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders Read More...